Epidemiology in Public Health Flashcards

1
Q

Describe prevention in public health

A
  • Considers baseline risk, strength of relationship between risk factor and outcome, and prevalence in population (attributable risk and population attributable risk).
  • Occurs at different levels of the population (individual/high-risk vs. population) and at different stages of developing an outcome (primary, secondary and tertiary).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Detail the different levels of prevention strategy

A
  • Primary: aims to stop outcome by preventing or removing an exposure to a risk factor (via high risk or population approaches)
  • Secondary: aims to interrupt outcome in early to mid-stages by early detection (screening) and treatment
  • Tertiary: aims to reduce complications and severity of an established outcome through treatments and interventions. Treatment to reduce impact eg. diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Distinguish between population and high-risk strategies and when they are each best used

A

Individual/High Risk Approach:

  • focuses on reducing risk of individuals from high risk groups
  • good when interventions are costly and there are limited resources
  • those at greater risk are more likely to comply and get the greatest benefit
  • LIMITATIONS: level of risk varies within group, relies on compliance,can be stigmatising and places burden of responsibility on high risk groups, may not seek to change circumstances of exposure to high risk factors (eg. vaccination rather than contaminated water source), smaller level of public health impact.

Population/Absolute Risk Approach:

  • focuses on reducing absolute risk of outcome associated with exposure to a risk factor
  • individuals have varying degrees of exposure for many outcomes
  • many people exposed to low risk creates more cases than few people with high exposure - greater public health impact
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the prevention paradox

A
  • Rose, 1992
  • A measure that brings large benefits to the community offers little to each participating individual
  • Often requires social attitudes/pressure, economic incentives or legislation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the different types of dose-response profiles

A

Threshold dose

  • Risk of adverse outcome increases rapidly after threshold point.
  • Intervention should be targeted near the threshold point.

Linear

  • Greater exposure = greater risk
  • Population level behaviour change required to reduce risk via promotion and legislation

Curved Linear

  • Risk of outcome increases with exposure but lower at low levels
  • If outcome occurs at low exposure requires population approach
  • If outcome occurs at high exposure requires targeted approach

J-shaped/U-Shaped

  • Increased risk of outcome at high and low levels of exposure
  • Requires targeted interventions as cannot shift the population too far either way.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the purpose of screening programs?

A
  • Key preventative intervention strategy that enables early detection and treatment
  • Can be high-risk or population
  • Can be systematic or opportunistic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List criteria for assessing appropriateness of screening programs

A
  • Availability of effective and reliable screening method
  • Availability of intervention to reduce or improve outcome
  • Safety and acceptability of the test to the individual
  • Benefits must outweigh any harm
  • Should consider cost of relative burden (cost of screening vs. cost saving for being fewer patients) and operational feasibility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is the validity and reliability of screening methods evaluated?

A

Validity

  • Based on ability of screening method to distinguish between individuals with and without the condition of interest
  • How well can it predict disease - tested via sensitivity and specificity

Reliability

  • Based on how consistent the results of the test are when the test is repeated (with the same person under the same conditions)
  • Predictive value (negative and positive) - based on sensitivity and specificity of the screening method
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe ‘sensitivity’

A

The proportion of those who have the outcome who are correctly identified
-> True positives

= Number of true positives / Number of those with the outcome

  • Low sensitivity creates a high number of false negatives
  • Need high sensitivity for infectious degree control to prevent transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe ‘specificity’

A

The proportion of those who do not have the outcome who are correctly identified
-> True negatives

= Number of true negatives / Number of those without the outcome

  • Low specificity creates a high number of false positives (those incorrectly identified to have the outcome)
  • High specificity is preferred when confirmation of outcome is invasive or expensive, or if the result is stigmatising
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe ‘positive predictive value’

A

The likelihood of having outcome based on test result

= Number of true positives / Number of tested positives

  • High PPV = high levels of specificity
  • Less likely for someone with a negative result to have the condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe ‘negative predictive value’

A

The likelihood of not having an outcome based on the test result

= Number of true negatives / number of tested negatives

  • High NPV = High level of sensitivity
  • Less likely for some with positive result not to have the outcome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the relationship between predictive value and prevalence

A
  • Predictive value is dependent on the prevalence of an outcome
  • PPV decreases and NPV increases as prevalence decreases because overall probability of becoming a case has declined
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss some of the other considerations required when measuring effectiveness of screening

A
  • Selection Bias: those who participate in screening often differ from those who don’t
  • Lead-time Bias: early detection appears to prolong survival but has no effect on the outcome
  • Length-time bias: screening is more likely to detect an outcome with a slow progression
  • Over-diagnosis: may never become symptomatic or die of another diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List and briefly define the four main methods of public health surveillance

A

Routine:

  • regular, systematic and accurate reporting of health outcomes
  • establishes baseline frequencies
  • can study incidence changes, assess interventions, hazards and cause-specific deaths
  • civil registrations, census, population health indicators

Passive

  • data collection at point of contact and/or practitioner reporting
  • many factors affect data quality
  • can lead to underreporting
  • health facility data, outcome registries, notifiable outcomes

Sentinel
- use of selected reporting sites (with capacity) when passive surveillance does not provide high quality data

Active

  • uses case-finding techniques, population surveys, review of clinical records
  • commonly used for outbreaks of collecting data on prevalence of known risk factors
  • useful for monitoring emergence or elimination of disease (particularly if lack of formal care)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss the importance of registries and notifiable outcome for surveillance

A
  • Outcome registries: can be used to identify participants for research; monitor incidence, prevalence and survival; evaluate effectiveness of screening, prevention, treatment and procedures, monitor and improve quality of care
  • Notifiable outcomes - mainly infectious outcomes, helps identify importations and stop transmission, respond to outbreaks
17
Q

What are the key indicators used in the monitoring of health interventions?

A

Monitoring = systematic and routine collection of evidence about the effectiveness of a health intervention over time

  • Process indicators: quantifiable markers that measure how process is being implemented in relation to pre-specified targets (shows bottlenecks and failures)
  • Outcome indicators: measure results or objectives of intervention. Often clinical. Often need to identify indicators of an outcome to measure impact
18
Q

What is the focus of public health program evaluations?

A
  • EFFECT: whether program has achieved delivery of intervention/service -> coverage
  • EFFECTIVENESS: whether program has a measurable impact on improving health outcomes
19
Q

What are they key study design issues in epidemiological research?

A

Need for critical appraisal in order to identify:

  • real associations
  • confounding effects
  • weak and biased methodology